Ferenc Sóti

Proof-of-Concept Trial of an α7 Nicotinic Agonist in Schizophrenia

Ann Olincy, Josette G. Harris, Lynn Johnson et al. · Archives of General Psychiatry · 2006 · 524 citations

Initial Phase 2 Trial of a Nicotinic Agonist in Schizophrenia

Robert Freedman, Ann Olincy, Robert W. Buchanan et al. · American Journal of Psychiatry · 2008 · 421 citations · Full text

Stable free radicals. Part I. A new principle governing the stability of organic free radicals

Roger W. Baldock, Paul Hudson, Alan R. Katritzky et al. · Journal of the Chemical Society Perkin Transactions 1 · 1974 · 106 citations

Radical Emission, Engineering, Organic Free Radicals +17

Effects of an Alpha 7-Nicotinic Agonist on Default Network Activity in Schizophrenia

Jason R. Tregellas, Jody Tanabe, Donald C. Rojas et al. · Biological Psychiatry · 2010 · 105 citations

Psychiatry, Psychotic Disorder, Addiction +12

Hydroxy Metabolites of the Alzheimer's Drug Candidate 3-[(2,4-Dimethoxy)Benzylidene]-Anabaseine Dihydrochloride (GTS-21): Their Molecular Properties, Interactions with Brain Nicotinic Receptors, and Brain Penetration

William R. Kem, Vladimir M. Mahnir, László Prókai et al. · Molecular Pharmacology · 2004 · 101 citations